1. Home
  2. GBIO vs ATLO Comparison

GBIO vs ATLO Comparison

Compare GBIO & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.55

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Logo Ames National Corporation

ATLO

Ames National Corporation

N/A

Current Price

$22.98

Market Cap

205.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GBIO
ATLO
Founded
2016
1903
Country
United States
United States
Employees
N/A
231
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
205.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GBIO
ATLO
Price
$5.55
$22.98
Analyst Decision
Buy
Analyst Count
5
0
Target Price
$8.88
N/A
AVG Volume (30 Days)
60.0K
27.2K
Earning Date
11-05-2025
01-23-2026
Dividend Yield
N/A
3.47%
EPS Growth
N/A
82.57
EPS
N/A
1.80
Revenue
$15,270,000.00
$60,568,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.85
Revenue Growth
N/A
18.60
52 Week Low
$3.00
$16.04
52 Week High
$12.40
$24.36

Technical Indicators

Market Signals
Indicator
GBIO
ATLO
Relative Strength Index (RSI) 58.47 60.80
Support Level $5.20 $22.62
Resistance Level $5.70 $24.12
Average True Range (ATR) 0.23 0.53
MACD 0.04 -0.09
Stochastic Oscillator 81.00 52.20

Price Performance

Historical Comparison
GBIO
ATLO

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

Share on Social Networks: